脑部放疗，上午比下午敏感许多！ \, r. w3 f( N
- w3 N% w1 k9 J& o& V; E! ^& n2 `- G4 l3 {7 d; [& n3 V
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 T# ~1 V3 E; V7 a
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?; r( B# W& s- b F
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
: }# G5 W. _. Z$ U' sSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.) T3 _" j0 F6 W+ V5 x+ k5 B
: V) X( h+ S; J3 M) _7 a9 E3 ]1 e
Abstract$ W( q- _, z7 C+ l7 w
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.! \' u; U7 z7 K8 U: ?2 l. o3 |
0 H5 Y4 p4 R7 G! U1 f7 [+ ^METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
- O* u' Q4 G& ^1 U% ]' l4 m
+ o" r' Q( w% \; d6 GRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
+ x) W% B# M3 V$ u1 ^6 Q' P' j8 b+ r( ~
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
u8 T; d" V1 G* M# U$ w5 q1 u' S+ @/ C# m' I
|
% O, z$ F- t( e7 k, d4 k9 K, @
显身卡
